News2020-03-17T00:27:19+00:00

Stay in the know

Discover the latest financial news and exclusive features from Laidlaw

A BRIGHTER FUTURE, with Laidlaw. Episode #5 Laidlaw Five with David Garrity Session 3 episode of A Brighter Future

Podcast Series: A BRIGHTER FUTURE. Listen to our third session of the Laidlaw Five, our ongoing podcast series.

March 23rd, 2020|News, Podcasts|

David Garrity: New ’Stay-At-Home’ Paradigm Favors Big Tech

In the spirit of the Chinese curse, “may you live in interesting times,” we are certainly in the thick of it at the moment as efforts to contain the COVID-19 coronavirus to China have failed. There are now 140 countries that have reported infections and the weekend has seen the announcement of radical steps such as major U.S. cities (e.g. Chicago, IL; Los Angeles, CA; New York, NY) taking steps to sharply curtail public activities as the U.S. Centers for Disease Control & Prevention (CDC) has issued guidance that events involving 50 people or more not be held for the next two months...

March 17th, 2020|David Garrity|

Laidlaw & Company enhances their Wealth Management offering with Envestnet | MoneyGuide

Laidlaw & Company enhances their Wealth Management offering with Envestnet | MoneyGuide NEW YORK, NY, UNITED STATES, March 11, 2020 /EINPresswire.com/ -- Laidlaw Wealth Management is pleased to announce it has chosen Envestnet, a [...]

March 17th, 2020|News, press release|

How artificial intelligence can control disease outbreaks

Watch Ann Marie Sastry's interview on CNBC's “Squawk Alley”. The CEO of AMESITE talks about her company and how artificial intelligence can be used in disease outbreaks and even to track the coronavirus. WATCH [...]

February 28th, 2020|News|

Laidlaw served as Co-Manager on the $21.75mm EyePoint Pharmaceuticals (EYPT) Follow-On Offering.

Laidlaw Capital Markets is pleased to announce today's pricing of a $21,750,000 Follow-On Offering for EyePoint Pharmaceuticals (EYPT). Laidlaw proudly served as Co-Manager alongside Guggenheim, who was Sole Book-Runner on the transaction. See full Press [...]

February 21st, 2020|News, press release|

Laidlaw served as Sole Book-Runner on the $10mm BioSig Technologies (BSGM) Follow-On Offering.

Laidlaw Capital Markets is pleased to announce today's pricing of a $10,000,000 Follow-On Offering for BioSig Technologies (BSGM). Laidlaw proudly served as the Sole Book Runner on the transaction. See full Press Release on BioSig Website [...]

February 21st, 2020|News, press release|

Defiance ETFs LLC Rings The Closing Bell®

Laidlaw was proud too attend the closing bell ceremony at the NYSE yesterday. Defiance ETFs LLC is the first 5G ETF (NYSE Arca: FIVG) Alex Shtaynberger, Keith Hassan and Richard Calhoun from Laidlaw attended and [...]

February 7th, 2020|News|

Laidlaw served as Co-Manager on the $90mm Ziopharm Oncology (ZIOP) Follow-On Offering

Laidlaw Capital Markets is pleased to announce today’s pricing of a $90,000,000 Follow-On Offering for Ziopharm Oncology (ZIOP). Laidlaw proudly served as Co-Manager alongside Jefferies, who was Sole-Book Runner on the transaction. See full Press [...]

February 5th, 2020|News, press release|
Load More Posts

Ready to talk?

Discover how our informed approach will help you achieve your financial goals

Contact Us